JCNRJournal of Clinical and Nursing Research2208-36852208-3693Bio-Byword Scientific Publishing Pty. Ltd.10.26689/jcnr.v7i3.4903ArticleAnalysis of Serum Cys-C, TBA, and Routine Blood Parameters of Patients with Hepatitis B-Related Decompensated Cirrhosishttps://artdesignp.com/journal/JCNR/7/3/10.26689/jcnr.v7i3.4903LiYu,LvYifei,XiFeng-Yu,GaoYing2023732023-05-29Objective: To study the levels of serum cystatin C (Cys-C), total bile acid (TBA), and other routine blood parameters on patients with decompensated hepatitis B cirrhosis. Methods: Study group 1 consisted of 30 patients with hepatitis B-related decompensated cirrhosis, and study group 2 consisted of 30 patients with hepatitis B; while the control group consisted of 30 healthy people who underwent physical examination. The blood parameters were used to evaluate the clinical treatment effect of patients. Results: The TBA, Cys-C, alanine transaminase (ALT), total bilirubin (TBIL), aspartate aminotransferase (AST), and international normalized ratio (INR) in study group 1  were significantly higher than those of study group 2 and the control group; while the platelet count (PLT), hemoglobin (Hb), albumin (ALB), and estimated glomerular filtration rate (eGFR) were significantly lower in the study group 1 compared to the control group and study group 2 (P < 0.05). The Cys-C, PLT, TBA, AST, TBIL, and INR of patients in study group 1 who were successfully treated were significantly lower than the patients who were not successfully treated (P < 0.05). Conclusion: Serum Cys-C, TBA, and routine blood parameters are useful in predicting the condition and the prognosis of patients of hepatitis B-related decompensated cirrhosis.

Han S, Zhang Y, Gao S, et al., 2021, Analysis of the Application Value of Serum Cys-C, TBA and Blood Routine Indicators in Patients with Decompensated Hepatitis B Cirrhosis. Marker Immunoassay and Clinic, 28(06): 932–936 + 954.

Liu Y, Zhen Z, Wang H, et al. 2021, The Predictive Value of Serum-Ascites Albumin Gradient on the Risk of EVB in Patients with Decompensated Hepatitis B Cirrhosis. Journal of Practical Hepatology, 24(5): 637–640.

Wu S, Zhao X, Zhang J, et al. 2022, Effects of Entecavir combined with Compound Biejia Ruangan Tablets on Serum Liver Fibrosis and Hepatitis B Virus-Related Indicators in Patients with Active Compensated Hepatitis B Cirrhosis. Chinese Medicine and Clinical Medicine, 22(3): 269–272.

Chen J, Li J, Hu Y, 2021, Serum Virology and Biochemical Indicators in Patients with Decompensated Liver Cirrhosis After Hepatitis B. Journal of Taishan Medical College, 42(1): 66–68.

Zhou H, Pi X, Zhou G, et al. 2021, Analysis of the Relationship Between Serum Globulin/Cholinesterase and the Degree of Liver Injury and Complications of Decompensated Cirrhosis. New Medicine, 52(10): 778–781.

Gao L, 2022, Diagnostic Value of Contrast-Enhanced Ultrasonography + Ultrasound Portal Hemodynamics Combined with Serum Index Detection in Patients with Decompensated Liver Cirrhosis. Heilongjiang Medicine, 35(1): 189–191.

Xu X, Ding H, Li W, et al., 2019, Guidelines for the Diagnosis and Treatment of Liver Cirrhosis. Journal of Clinical Hepatobiliary Diseases, 35(11): 2408–2425.

Yu C, 2021, Analysis of the Expression Value and Clinical Significance of Blood Biochemical Indicators and Fibrosis Indicators in Patients with Liver Cirrhosis. China Medical Innovation, 18(14): 159–163.

Duan Y, Wu G, 2023, Research on the Clinical Application Value of Serum LncRNA NEAT1 and LncRNA H19 in NAFLD and Liver Fibrosis. International Journal of Laboratory Medicine, 44(1): 59–62 + 68.

Gong X, Wan S, Fu C, 2021, Expression and Clinical Significance of miR-223 in Serum of Patients with Hepatitis B Virus and Advanced Liver Fibrosis. Chinese Journal of Pathogen Biology, 16(10): 1202–1206.

Wu Y, Liu Y, Chen P, et al., 2022, Application Value of 2D-SWE, FIB-4 Index Combined with Liver Biochemical Indicators in Patients with Hepatitis B Cirrhosis. Chinese Medical Science, 12(3):197–200.

Zhou H, Zhou J, Zhu J, 2021, The Application Value of Serum NGAL, Scr and TBil in the Prognosis Assessment of Patients with Chronic Hepatitis B Cirrhosis. Journal of Integrative Traditional Chinese and Western Medicine Hepatology, 31(12): 1085–1088 .

Zhao Q, 2022, Application Value Analysis of Serum Cys -C and SAA Test in Diagnosis, Treatment and Prognosis of Coronary Heart Disease. Journal of Mathematics and Medicine, 35(3): 421–423.

Zhang L, Cai M, 2022, Application of Serum Total Cholesterol, Serum Albumin and Cholinesterase Levels in Liver Function Assessment in Patients with Hepatitis Cirrhosis. Jilin Medicine, 43(2): 482–484.

Ding Y, 2018, The Application Value of Four Coagulation Items Combined with Serum TBA and CHE Level Detection in the Assessment of Patients with Viral Hepatitis. Henan Medical Research, 27(22): 4117–4118.

Hu L, 2021, The Application Value of Serum Indicators in the Diagnosis of Liver Fibrosis in Patients with Chronic Hepatitis B. Medical Tribune, 42(22): 43–46.